Overexpression of NUDT19 and the mTORC1 activator MYH1485 reverse the inhibitory effects of LINC00958 silencing on HCC proliferation, migration, and epithelial‐mesenchymal transition (EMT),[22, 23] and a large number of newly identified lncRNAs that are specifically expressed in tumor groups were found (Figure 4A; Table S6, Supporting Information). Here, LINC00958 is linked to hepatocellular carcinoma.